Integration of Immunotherapy for Non-Small Cell Lung Carcinoma: Current and Future Perspectives is organized by American Society for Radiation Oncology (ASTRO) and will be held from Feb 05, 2017 - Feb 04, 2020.

The target audience for this medical event is radiation oncologists, medical oncologists, surgeons, radiation biologists and specialists. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credits.

Learning Objectives
• Describe the strategies used to incorporate immunotherapeutic medications with radiation therapy in patients with LA- NSCLC.
• Describe how Investigators are attempting to incorporate immune checkpoint inhibitors with radiation therapy in patients with NSCLC.

Additional details will be posted as soon as they are available.

Intended Audience

Radiation Oncology, Immunotherapies

Activity Payment Details

Activity Fee : USD $105.00

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


American Society for Radiation Oncology (ASTRO)

View Organizer Details